Previous 10 | Next 10 |
2024-03-08 17:04:33 ET More on Graphite Bio Graphite Bio: Reverse Merger Leading Into Big Special Dividend And Q2 Phase 3 Trial Seeking Alpha’s Quant Rating on Graphite Bio Historical earnings data for Graphite Bio Financial information for Graphite Bi...
Special dividend estimated to be $1.03 per share Payment of special dividend conditioned upon closing of merger Graphite Bio, Inc. (Nasdaq: GRPH) (“Graphite” or the “Company”) today announced that its Board of Directors has declared a special dividend...
2024-02-05 16:55:17 ET Gainers: Semper Paratus Acquisition ( LGST ) +13% . Graphite ( GRPH ) +12% . Varonis Systems ( VRNS ) +8% . NXP Semiconductors ( NXPI ) +3% . Spruce Biosciences ( SPRB ) +3% . Losers: Sy...
2023-12-25 05:22:26 ET Summary Graphite Bio announces a reverse merger with LENZ Therapeutics, with GRPH shareholders receiving a $60 million dividend. Graphite Bio stockholders are expected to own 35% of the combined company before the PIPE financing. The combined company is ...
NEW YORK, NY / ACCESSWIRE / December 11, 2023 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Cerevel Therapeutics Holdings, In...
NEW YORK, NY / ACCESSWIRE / November 18, 2023 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: CapStar Financial Holdings, Inc. ...
2023-11-16 15:54:01 ET More on CRISPR Therapeutics CRISPR Therapeutics: Positive Exa-Cel AdCom Opens Door For Historic Approval Risk And Reward: Evaluating Crispr's Exa-Cel For Sickle Cell Crispr: Upcoming Catalysts, Plenty Of Cash And Strong Partnerships Make It A B...
NEW YORK, NY / ACCESSWIRE / November 15, 2023 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Graphite Bio, Inc. (NASDAQ:GRP...
2023-11-15 08:24:52 ET Graphite Bio GRPH -15% following reverse merger with LENZ Therapeutics in all-stock deal . Global E Online GLBE -15% on Q3 earnings release . Tivic Health Systems TIVC -15% on Q3 earnings release . reAlpha Tech ( AIRE ) -14%...
2023-11-15 07:36:44 ET More on Graphite Bio Seeking Alpha’s Quant Rating on Graphite Bio Historical earnings data for Graphite Bio Financial information for Graphite Bio For further details see: Graphite Bio in reverse merger with LENZ Therapeutics...
News, Short Squeeze, Breakout and More Instantly...
Lendway Inc. (LDWY) is expected to report for quarter end 2023-12-31 Hongchang International Co Ltd Com (New) (HCIL) is expected to report for Q4 2023 BioStem Technologies Inc (BSEM) is expected to report $0.47 for Q4 2023 Nicox SA (NICXF) is expected to report $-0.07 for Q4 2023 ...
Special dividend estimated to be $1.03 per share Payment of special dividend conditioned upon closing of merger Graphite Bio, Inc. (Nasdaq: GRPH) (“Graphite” or the “Company”) today announced that its Board of Directors has declared a special dividend...
NEW YORK, NY / ACCESSWIRE / December 11, 2023 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Cerevel Therapeutics Holdings, In...